𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Targeting mTOR in renal cell carcinoma

✍ Scribed by Gary R. Hudes

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
153 KB
Volume
115
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Telomerase activity in renal cell carcin
Telomerase activity in renal cell carcinoma
✍ Ken-ichiro Yoshida; Shu-ichi Sakamoto; Shuhei Sumi; Yotsuo Higashi; Satoshi Kita πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 2 views

## BACKGROUND. Telomerase activity has been shown to be increased in numerous tumors and cell lines, although to the authors' knowledge there has been no previous assessment of telomerase activity in renal cell carcinoma (RCC). To examine whether telomerase activity could be used as a biochemical p

Sequential therapy in renal cell carcino
Sequential therapy in renal cell carcinoma
✍ Bernard Escudier; Marine Gross Goupil; Christophe Massard; Karim Fizazi πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 1 views
Clinical research priorities in Renal ce
Clinical research priorities in Renal cell carcinoma : Renal cell carcinoma chemoprevention strategies including target populations, proposed agents, and clinical trial designsβ€”Workgroup No. 6
✍ Kamal A. Hanash; Joseph W. Aquilina; David M. Barrett; Michael L. Blute; Abraham πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 50 KB πŸ‘ 2 views

C hemoprevention refers to the prevention of cancer or reduction of risk in susceptible individuals by the administration of natural or synthetic drugs with minimal toxicity to suppress, delay, or reverse carcinogenesis. 1 Chemoprevention is most effective in the early stages of cancer formation whe